BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 5.03
-0.19 (-3.64%)
Jul 24, 2026, 3:59 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 43.76 million as of July 24, 2026. Its market cap has increased by 476.61% in one year.
Market Cap
43.76M
Enterprise Value
11.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.03
ChartMarket Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 43.76M, an increase of 79.22%. That is a compound annual growth rate of 5.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 43.76M | 137.02% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 68.20M |
| MedMira | 45.61M |
| NurExone Biologic | 45.60M |
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 41.33M |
| Onco-Innovations | 41.10M |
| Resverlogix | 36.10M |
| Telescope Innovations | 35.55M |